A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/1997
11/26/1997	CN1166171A N-substituted piperidinyl bicyclic benzoate derivatives
11/26/1997	CN1165857A Strains of bacteria, pharmaceutial composition containing one or more of such strains and use of same for preventing and treating deseases associated with or caused by altered metaolism of bile
11/26/1997	CN1165679A Classified liver treating agent and it prepn. method
11/25/1997	US5691382 Enzyme inhibitors for cardiovascular disorders
11/25/1997	US5691381 Antagonist of tumor necrosis factor, antiinflammatory agent, antiarthritic agent
11/25/1997	US5691374 Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
11/25/1997	US5691370 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2-adrenoceptor agonists
11/25/1997	US5691343 Crohn*s disease
11/25/1997	US5691336 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
11/25/1997	US5690960 Magnesium salt; oral form
11/25/1997	CA2132541C Quinuclidine derivatives as substance p antagonists
11/20/1997	WO1997043278A1 Somatostatin agonists and antagonists
11/20/1997	WO1997043272A2 Benzofurans and benzopyrans as chronobiological agents
11/20/1997	WO1997043247A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
11/20/1997	WO1997043245A1 Inhibition of matrix metalloproteases by acetylene containing compounds
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997	WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
11/20/1997	WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997	WO1997042941A2 Buccal delivery system
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	WO1997030677A3 Pentafluorobenzenesulfonamides and analogs
11/20/1997	DE19720437A1 Oral composition for plaque suppression and removal
11/20/1997	CA2253802A1 Benzofurans and benzopyrans as chronobiological agents
11/19/1997	EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/19/1997	EP0807639A2 Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
11/19/1997	EP0807633A2 Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
11/19/1997	EP0807629A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them
11/19/1997	EP0807627A2 Anilide compounds as ACAT inhibitors
11/19/1997	EP0807621A1 Derivatives of phenylglycine and use thereof as pharmaceuticals
11/19/1997	EP0807114A1 Bridged indoles as matrix metalloprotease inhibitors
11/19/1997	EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997	EP0807110A1 Enterokinetic benzamide
11/19/1997	EP0806954A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
11/19/1997	EP0806949A1 New pharmaceutical composition containing trimebutine and preparation process
11/19/1997	EP0806947A1 Formulations and methods for reducing skin irritation
11/19/1997	EP0806940A1 Aerosol drug formulations
11/19/1997	CN1165035A Antigen-antibody-recombination DNA composite type vaccin
11/19/1997	CN1165000A Method of reducing tissue damage associated with ischemia
11/18/1997	US5688960 Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
11/18/1997	US5688957 (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1997	US5688943 Cholecystokinin antagonist; antiulcer agents; psychological drugs; anxiolytic agents; controlling appetite
11/18/1997	US5688825 Sulfonyloxysuccimides
11/18/1997	US5688820 Nervous system disorders; psychological disorders
11/18/1997	US5688815 Hydroxypyridinones
11/18/1997	US5688811 Psychological disorders; nervous system disorders
11/18/1997	US5688799 9-Hydroxy-pyrido 1,2-a!pyrimidin-4-one ether derivatives
11/18/1997	US5688793 Pyridazino 4',5':3,4!pyrrolo- 2,1-a!-isoquinolines and the use thereof for preparing pharmaceutical preparations
11/18/1997	US5688788 N-substituted azaheterocyclic carboxylic acids and esters thereof
11/18/1997	US5688665 Binding to cyclin dependent kinases; controlling cell reproduction
11/18/1997	US5688521 Lactulose pastilles
11/18/1997	CA2122360C Quinazolinone antianginal agents
11/15/1997	CA2205477A1 Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/13/1997	WO1997041875A1 Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
11/13/1997	WO1997041853A1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
11/13/1997	WO1997041838A1 Non-aqueous colonic purgative formulations
11/13/1997	WO1997041824A2 Antiangiogenic peptides derived from plasminogen
11/13/1997	CA2253913A1 Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
11/13/1997	CA2253860A1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
11/13/1997	CA2204846A1 Pharmaceutical compounds
11/12/1997	EP0806419A1 Benzoxazole derivatives as serotonin 5-HT3 receptor partial activator
11/12/1997	EP0806204A1 Inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient
11/12/1997	EP0805820A1 Ligands for eph-like receptors
11/12/1997	EP0805815A1 Bismuth compounds
11/12/1997	EP0805813A1 Tricyclic vasopressin antagonists
11/12/1997	EP0805796A1 Cell adhesion inhibitors
11/12/1997	EP0730465A4 Use of angiotensin iii and analogs thereof in tissue repair
11/12/1997	CN1164537A New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions contianing them
11/12/1997	CN1164421A Preparation of drug for curing chronic fibrosis hepatic disease and acute hepatic disease using bradyknin-antagonist
11/12/1997	CN1164405A Nishatong medicine for curing hepatic disease and coniasis
11/12/1997	CN1164401A Shuweiping-drug for curing gastropathy
11/12/1997	CN1164396A Ecological enema liquid for curing functional constipation
11/12/1997	CN1036394C Method for preparation of carbostyril derivatives
11/12/1997	CN1036392C Method for preparation of ring-substituted 2-amino-tetralin and 3-aminochromanes
11/11/1997	US5686622 Thiazolidine derivatives, their preparation and the medicaments containing the same
11/11/1997	US5686496 Aromatic ether amidine used for treating diseases involve inflammatory and/or allergic processes
11/11/1997	US5686485 Physiologically active EI-1941 compounds
11/11/1997	US5686475 Application of riluzole in the treatment of mitochondrial diseases
11/11/1997	US5686458 Quinazoline deriviates for treating peptic ulcer
11/11/1997	US5686449 1,5-benzodiazepines useful as gastrinor CCK-antagonists
11/11/1997	US5686431 Methods of using low molecular weight heparins for treatment of pathological processes
11/11/1997	US5686426 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
11/11/1997	US5686415 Method for the treatment of colon epithelial cells in vivo
11/11/1997	CA2130563C 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist
11/06/1997	WO1997041232A1 Antagonists of interleukin-15
11/06/1997	WO1997041114A1 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
11/06/1997	WO1997041103A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/06/1997	WO1997040854A2 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997	WO1997040848A1 Use of prolactin as a tgf-beta antagonist
11/06/1997	WO1997040811A1 Storage stable dentifrice composition containing casein glycomacropeptide
11/06/1997	CA2253282A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/06/1997	CA2252706A1 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997	CA2252557A1 Antagonists of interleukin-15
11/06/1997	CA2232682A1 Use of prolactin as a tgf-beta antagonist
11/05/1997	EP0804542A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same
11/05/1997	EP0804479A1 Method of treating diabetes mellitus using kgf
11/05/1997	EP0804469A1 Novel peptide
11/05/1997	EP0804468A1 Conformationally constrained backbone cyclized peptide analog
11/05/1997	EP0804465A1 Novel elastase inhibitors

1 ... 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 ... 1258